Albendazole Therapy Considerations

Primary Side Effects and Monitoring

The American College of Physicians recommends monitoring for hepatotoxicity and leukopenia when albendazole treatment exceeds 14 days, with a reported incidence of leukopenia in up to 10% of patients and elevated liver enzymes in up to 16% of cases 1, 2
Headaches, seizures, and dizziness are common side effects, primarily due to parasiticidal activity and treatment-induced inflammation, with a transient increase in seizure frequency occurring after therapy initiation in neurocysticercosis patients 1, 2
Reversible alopecia occurs in 2% of patients 1, 2

The Infectious Diseases Society of America notes that praziquantel significantly increases albendazole exposure, but co-administration is safe and commonly recommended, with no additional monitoring needed beyond standard albendazole monitoring 1, 2, 3
Dexamethasone increases albendazole sulfoxide trough concentrations by approximately 56%, which may be therapeutically beneficial in neurocysticercosis treatment, but reduces praziquantel levels due to increased metabolism 1, 4, 5

The Centers for Disease Control and Prevention recommend fundoscopic examination prior to initiation to detect retinal cysticercosis, as well as screening or providing empiric therapy for Strongyloides stercoralis in patients requiring prolonged corticosteroids 6, 3, 7, 8
Patients with pre-existing elevated liver enzymes are at increased risk for both hepatotoxicity and bone marrow suppression, and undiagnosed neurocysticercosis may be uncovered in patients treated for other parasitic conditions 6, 3, 7, 8

The World Health Organization recommends taking albendazole with food, especially fatty meals, to improve absorption 1, 2

The World Health Organization is not cited, however, Albendazole should be administered with meals, specifically with fatty food, to maximize absorption and therapeutic efficacy 9
For tissue parasites, administration with fatty meals is essential because systemic absorption is required for therapeutic effect 9

Administer 15 mg/kg/day divided into 2 daily doses (maximum 1200 mg/day) for 10-14 days with food 10, 9
For patients with single enhancing lesions, give albendazole 15 mg/kg/day in twice-daily doses for 1-2 weeks with meals 9

For patients with single enhancing lesions treated with antiparasitic drugs, initiate corticosteroids prior to starting albendazole to mitigate treatment-induced inflammation 9

The Annals of Oncology recommends avoiding liquid paraffin when administering albendazole because it significantly impairs the absorption of albendazole, which requires fatty meals for optimal therapeutic efficacy 11
Liquid paraffin is a mineral oil that acts as a lubricant laxative and is specifically NOT recommended in advanced disease management due to multiple safety concerns, including interference with the absorption of fat-soluble substances and medications 11
Liquid paraffin carries additional risks including aspiration leading to lipoid pneumonia, anal seepage, skin excoriation, and foreign body reactions if there is a break in the anorectal mucosa 11

The Annals of Oncology recommends using osmotic laxatives such as polyethylene glycol (PEG/Macrogol) or lactulose instead of liquid paraffin, as these agents do not interfere with drug absorption 11
Magnesium salts can be used cautiously in patients without renal impairment 11

The Annals of Oncology suggests avoiding any agents that could coat the gastrointestinal tract or interfere with fat absorption during the treatment period 11
For neurocysticercosis treatment, the Clinical Infectious Diseases journal notes that reduced albendazole absorption could lead to treatment failure, highlighting the importance of proper administration 12